We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Roche Adds Antibody Discovery Platform With THP Acquisition
Roche Adds Antibody Discovery Platform With THP Acquisition
April 2, 2007
Roche expanded its preclinical drug-discovery platforms with a $56.5 million acquisition of Therapeutic Human Polyclonals (THP), the firm said.